Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Dr. Jay Philip SiegelInsider | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Mr. Scott T. JacksonIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Dr. Margaret A. LiuIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Ms. Meenu Chhabra KarsonIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Dr. William K. HeidenIndependent Chairman of the Board | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 114,75k | 3,38% |
| 2026-05-18 | Ms. Federica F. O'BrienIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Mr. Edward M. HurwitzIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 47,82k | 8,51% |
| 2026-05-18 | Dr. David C. StumpIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-05-18 | Dr. Karen Jean FerranteIndependent Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 14,75k | 34,09% |
| 2026-02-15 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | 10,23k | 0,00 | Derivative Exercise and Retained Stock | - | 145,80k | 7,55% |
| 2026-02-15 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | -6,43k | 11,00k | Derivative Exercise and Sale | 1,71 | 145,80k | - |
| 2026-02-15 | Mr. James KarrelsSenior VP & CFO | 9,21k | 0,00 | Derivative Exercise and Retained Stock | - | 206,04k | 4,68% |
| 2026-02-15 | Mr. James KarrelsSenior VP & CFO | -5,79k | 9,90k | Derivative Exercise and Sale | 1,71 | 206,04k | - |
| 2026-02-15 | Ms. Beth SmithVP, Controller & Treasurer | 672,00 | 0,00 | Derivative Exercise and Retained Stock | - | 12,78k | 5,55% |
| 2026-02-15 | Ms. Beth SmithVP, Controller & Treasurer | -423,00 | 723,33 | Derivative Exercise and Sale | 1,71 | 12,78k | - |
| 2026-02-15 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | 8,19k | 0,00 | Derivative Exercise and Retained Stock | - | 31,11k | 35,71% |
| 2026-02-15 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | -5,15k | 8,80k | Derivative Exercise and Sale | 1,71 | 31,11k | - |
| 2026-02-15 | Dr. Thomas M. SpitznagelSVP of Technical Operations | 7,81k | 0,00 | Derivative Exercise and Retained Stock | - | 38,54k | 25,42% |
| 2026-02-15 | Mr. Eric Blasius RisserCEO, President & Director | 10,23k | 0,00 | Derivative Exercise and Retained Stock | - | 77,17k | 15,29% |
| 2026-02-15 | Mr. Eric Blasius RisserCEO, President & Director | -6,43k | 11,00k | Derivative Exercise and Sale | 1,71 | 77,17k | - |
| 2026-02-15 | Dr. Thomas M. SpitznagelSVP of Technical Operations | -5,52k | 9,44k | Derivative Exercise and Sale | 1,71 | 38,54k | - |
| 2026-02-15 | Dr. Scott KoenigDirector | 21,17k | 0,00 | Derivative Exercise and Retained Stock | - | 867,24k | 2,50% |
| 2026-02-08 | Dr. Scott KoenigDirector | 15,83k | 0,00 | Derivative Exercise and Retained Stock | - | 846,08k | 1,91% |
| 2026-02-07 | Dr. Thomas M. SpitznagelSVP of Technical Operations | 9,33k | 0,00 | Derivative Exercise and Retained Stock | - | 30,73k | 43,59% |
| 2026-02-07 | Dr. Thomas M. SpitznagelSVP of Technical Operations | -5,67k | 10,26k | Derivative Exercise and Sale | 1,81 | 30,73k | - |
| 2026-02-07 | Mr. Eric Blasius RisserCEO, President & Director | 10,95k | 0,00 | Derivative Exercise and Retained Stock | - | 66,94k | 19,55% |
| 2026-02-07 | Mr. Eric Blasius RisserCEO, President & Director | -6,89k | 12,46k | Derivative Exercise and Sale | 1,81 | 66,94k | - |
| 2026-02-07 | Ms. Beth SmithVP, Controller & Treasurer | 2,58k | 0,00 | Derivative Exercise and Retained Stock | - | 12,11k | 27,04% |
| 2026-02-07 | Ms. Beth SmithVP, Controller & Treasurer | -1,62k | 2,94k | Derivative Exercise and Sale | 1,81 | 12,11k | - |
| 2026-02-07 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | 9,21k | 0,00 | Derivative Exercise and Retained Stock | - | 22,92k | 67,17% |
| 2026-02-07 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | -5,79k | 10,48k | Derivative Exercise and Sale | 1,81 | 22,92k | - |
| 2026-02-07 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | 11,15k | 0,00 | Derivative Exercise and Retained Stock | - | 135,57k | 8,96% |
| 2026-02-07 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | -7,01k | 12,70k | Derivative Exercise and Sale | 1,81 | 135,57k | - |
| 2026-02-07 | Mr. James KarrelsSenior VP & CFO | 10,03k | 0,00 | Derivative Exercise and Retained Stock | - | 196,83k | 5,37% |
| 2026-02-07 | Mr. James KarrelsSenior VP & CFO | -6,31k | 11,41k | Derivative Exercise and Sale | 1,81 | 196,83k | - |
| 2025-08-19 | Dr. William K. HeidenIndependent Chairman of the Board | 100,00k | 150,52k | Kauf | 1,49 - 1,52 | 111,00k | 909,09% |
| 2025-08-13 | Dr. Scott KoenigDirector | 52,83k | 0,00 | Derivative Exercise and Retained Stock | - | 830,24k | 6,80% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
